Sooma and Clariane announce a multi-country pilot for rehab. Read more

Skip to content

Sooma for Professionals

How it works
Testimonials
Publications
- Peer-reviewed studies
- Ongoing studies
Company
For patients

- English
- Suomi
- Deutsch
- Français
- Eesti
Contact us

Sooma Duo technical support

Useful links

Sooma DUO problem solving guidance document

Contact information

Atomitie 5 C
00370 Helsinki, Finland
Business / VAT ID: FI25272969

Contact us
Support

Links

Depression treatment
Pain management
Sooma tDCS™
Patient information
Publications
About Sooma
Newsroom
Portal Login

Legal

Terms and conditions
Privacy policy
Cookies

Follow us

LinkedIn

Subscribe to our newsletter

Sooma tDCS™ is a medical device used by healthcare professionals worldwide. The device has received regulatory approvals such as MDR, CE marking, Health Canada, MDA, HSA, and COFEPRIS. Sooma tDCS™ has also acquired US Breakthrough Device Designation and Investigational Device Exemption. Federal law in the United States currently limits Sooma tDCS™ devices to investigational use only. Sooma tDCS™ devices are designed in Finland under ISO 13485.

Sooma tDCS™ devices are protected by patents P1678US00, P1678EP01, and US10918855. Other patents pending.

© 2026 Sooma Medical

Made with love by MEOM